Peroxiredoxin 1 promotes tumorigenesis through regulating the activity of mTOR/p70S6K pathway in esophageal squamous cell carcinoma (Q28255305)

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Reactive oxygen species (ROS)--induced genetic and epigenetic alterations in human carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Suppression of basal autophagy reduces lung cancer cell proliferation and enhances caspase-dependent and -independent apoptosis by stimulating ROS formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Peroxiredoxin overexpression in MCF-7 breast cancer cells and regulation by cell proliferation and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Identification of a natural killer enhancing factor (NKEF) from human erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

The antioxidant enzyme Prdx1 controls neuronal differentiation by thiol-redox-dependent activation of GDE2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

RNA-binding properties and RNA chaperone activity of human peroxiredoxin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

An activated mTOR/p70S6K signaling pathway in esophageal squamous cell carcinoma cell lines and inhibition of the pathway by rapamycin and siRNA against mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Regulation of reactive oxygen species, DNA damage, and c-Myc function by peroxiredoxin 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Up-regulation of peroxiredoxin 1 in lung cancer and its implication as a prognostic and therapeutic target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Using proteomic approach to identify tumor-associated proteins as biomarkers in human esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-014-0455-0

Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25579166

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Peroxiredoxin 1 is a tumor-associated antigen in esophageal squamous cell carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25579166